Avacopan for the Treatment of ANCA-Associated Vasculitis.: Social discussions and analytics

Nephrology Insights 2022: New Treatments for Chronic Kidney Disease

Professor Marcus Säemann and colleagues discuss four emerging substances that will transform treatment strategies for patients with diabetic kidney disease, lupus, and ANCA-associated vasculitis. Finerenone, a notable…

MARKUS at HOMe · Jan 14, 2022 2,478 views

Best Practices for Glucocorticoid Therapy in Lupus Nephritis

Dr. Ali Duarte Garcia discusses optimal steroid treatment strategies for lupus nephritis patients based on his recent review in Nephrology Dialysis Transplantation. This session covers effective management approaches…

MARKUS at HOMe · May 23, 2025 716 views

Tskkm0117

@Tskkm0117 · X

RT @hama_nephro: 【ANCA関連血管炎へのアバコパンの有効性を評価したRCT ADVOCATE試験 NEJM2021】 https://t.co/WYfpD8zKFT ・AVA vs PSL (両群ともCY or RTX)にてAVAの寛解における非劣性示した・…

Jun 20, 2025 · 2 shares · 1 followers View post →

mocchi

@mocchi_ym · X

RT @hama_nephro: 【ANCA関連血管炎へのアバコパンの有効性を評価したRCT ADVOCATE試験 NEJM2021】 https://t.co/WYfpD8zKFT ・AVA vs PSL (両群ともCY or RTX)にてAVAの寛解における非劣性示した・…

Jun 20, 2025 · 2 shares · 213 followers View post →

腎攻

@hama_nephro · X

【ANCA関連血管炎へのアバコパンの有効性を評価したRCT ADVOCATE試験 NEJM2021】 https://t.co/WYfpD8zKFT ・AVA vs PSL (両群ともCY or RTX)にてAVAの寛解における非劣性示した・肝障害：AVA群5.4% ・選択的C5受容体抗体ということもあり, 補体の変動を見ている研究も多くあった⇨一部で,

Jun 20, 2025 · 16 likes · 2 shares · 1,197 followers View post →

2things

@2thingsteam · X

RT @medpedshosp: Avacopan for the Treatment of ANCA-Associated Vasculitis | New England Journal of Medicine - Using it for the first time t…

May 24, 2025 · 2 shares · 5,816 followers View post →

ACP Ohio

@OhioAcp · X

RT @medpedshosp: Avacopan for the Treatment of ANCA-Associated Vasculitis | New England Journal of Medicine - Using it for the first time t…

May 24, 2025 · 2 shares · 932 followers View post →

Med Peds Hospitalist

@medpedshosp.medsky.social · Bluesky

Avacopan for the Treatment of ANCA-Associated Vasculitis. Avacopan is a C5a receptor inhibitor. Using it for the first time today!!! www.nejm.org/doi/full/10....

May 19, 2025 · 1 like View post →

Med Peds Hospitalist

@medpedshosp · X

Avacopan for the Treatment of ANCA-Associated Vasculitis | New England Journal of Medicine - Using it for the first time today! https://t.co/BMLlj1fXyA

May 19, 2025 · 2 likes · 2 shares · 14,229 followers View post →

KIReports

@KIReports · X

8/

Sep 30, 2024 · 5 likes · 13,558 followers View post →

وادى النيل

@moataztawfik2 · X

Avacopan for the Treatment of ANCA-Associated Vasculitis | New England Journal of Medicine https://t.co/WsI8hOnU35

Sep 5, 2024 · 42 followers View post →

Abstream

@abstreamme · X

Avacopan for the Treatment of ANCA-Associated Vasculitis #science #publication #research #publications https://t.co/B7ZktA3I9X

Jan 29, 2024 · 786 followers View post →

にいやん

@niiyan51 · X

Avacopan for the Treatment of ANCA-Associated Vasculitis https://t.co/K12RjSy7VB

Jan 28, 2024 · 1,074 followers View post →

tiko

@tiko1127252 · X

RT @Ryu04196650Ryu: ANCA関連血管炎に対するavacopan関連のまとめツリー↓ https://t.co/yZ9JKPSqVE

Jan 26, 2024 · 6 shares · 118 followers View post →

Angela Córdoba Hurtado

@AngelaCordobaH · X

RT @carlo_alfieri: Avacopan for the Treatment of ANCA-Associated Vasculitis | NEJM correction https://t.co/ovvDVdWQug

Jan 26, 2024 · 1 share · 529 followers View post →

膠原病医つっしー

@RAtsussy · X

RT @Ryu04196650Ryu: ANCA関連血管炎に対するavacopan関連のまとめツリー↓ https://t.co/yZ9JKPSqVE

Jan 26, 2024 · 6 shares · 2,485 followers View post →

Hirotsugu Kitayama

@HirotsuguKitay1 · X

RT @Ryu04196650Ryu: ANCA関連血管炎に対するavacopan関連のまとめツリー↓ https://t.co/yZ9JKPSqVE

Jan 26, 2024 · 6 shares · 171 followers View post →

rakkozuki

@rakkozuki · X

RT @Ryu04196650Ryu: ANCA関連血管炎に対するavacopan関連のまとめツリー↓ https://t.co/yZ9JKPSqVE

Jan 26, 2024 · 6 shares · 45 followers View post →

Ryu

@Ryu04196650Ryu · X

ANCA関連血管炎に対するavacopan関連のまとめツリー↓ https://t.co/yZ9JKPSqVE

Jan 26, 2024 · 49 likes · 6 shares · 4,799 followers View post →

Carlo Alfieri

@carlo_alfieri · X

Avacopan for the Treatment of ANCA-Associated Vasculitis | NEJM correction https://t.co/ovvDVdWQug

Jan 25, 2024 · 1 like · 1 share · 764 followers View post →

Global Kidney Academy

@GKA_CME · X

Clinical trials have shown promising results in treating ANCA-associated vasculitis with #Avacopan. Explore this breakthrough: https://t.co/eEhJfSZnjA #MedTwitter #KidneyHealth

Dec 12, 2023 · 1 like · 803 followers View post →

george demirakos

@georgedemirakos · X

RT @JoseMeadeMD: #Abstractoftheday today from #ACR23 Important clarification and absolutely significant discussion about those patients tha…

Sep 26, 2023 · 2 shares · 975 followers View post →

Jaime Flores-Gouyonnet, MD

@JaimeFG_MD · X

RT @JoseMeadeMD: #Abstractoftheday today from #ACR23 Important clarification and absolutely significant discussion about those patients tha…

Sep 25, 2023 · 2 shares · 227 followers View post →

Jose A. Meade, MD

@JoseMeadeMD · X

#Abstractoftheday today from #ACR23 Important clarification and absolutely significant discussion about those patients that had #DAH with #avacopan. #TwitterAmbassador https://t.co/v2tn68uDXl https://t.co/irR3mIYO6c

Sep 25, 2023 · 12 likes · 2 shares · 3,947 followers View post →

Global Kidney Academy

@GKA_CME · X

8/8 Now let's catch up on an emerging therapy for AAV: Avacopan, an oral, selective C5a receptor inhibitor. In the ADVOCATE Phase 3 trial, Avacopan was superior to prednisone taper with respect to sustained remission at week 52. Investigate further: https://t.co/eEhJfSZnjA https://t.co/87DRPbefJL

Aug 2, 2023 · 1 like · 803 followers View post →

すいかの雑記帳

@suika_no_memo · X

Avacopan for the Treatment of ANCA-Associated Vasculitis | NEJM https://t.co/TSldOeTFHI ADVOCATE study。アバコパンの第Ⅲ相試験。PSLフリーでAAVの治療をすることって日本ではほぼないから導入するのが超難しいように思う。

Jun 25, 2023 · 167 followers View post →

Jim Moriarty

@HotKidneyAction · X

And the study she wishes she had presented... Avacopan for the Treatment of ANCA-Associated Vasculitis https://t.co/moOiqYsd6l #UKKW2023

Jun 5, 2023 · 1,100 followers View post →

Global Kidney Academy

@GKA_CME · X

Breaking down a treatment strategy for #ANCAAssociatedVasculitis. Learn more about this trial here: https://t.co/oiaYEzGJuk #Nephrology #MedTwitter #AAV

May 16, 2023 · 1 like · 803 followers View post →

Mehraj Ul islam

@Mehrajulislm · X

RT @KIReports: 4/ 17 In the ADVOCATE trial, the selective C5a receptor inhibitor Avacopan demonstrated superiority to prednisone for induc…

May 5, 2023 · 1 share · 163 followers View post →

KIReports

@KIReports · X

4/ 17 In the ADVOCATE trial, the selective C5a receptor inhibitor Avacopan demonstrated superiority to prednisone for inducing remission at 52 wks in AAV https://t.co/MHgYBRsx0X @NEJM PMID: 28529340 https://t.co/1ix8DJsj8c

May 5, 2023 · 4 likes · 1 share · 13,558 followers View post →

Ryu

@Ryu04196650Ryu · X

ADVOCATE (2021) @NEJM Avacopan for the Treatment of ANCA-Associated Vasculitis Avacopanは26wの寛解ではPSLと非劣勢、52w寛解維持率はPSLより高い https://t.co/yZ9JKPSqVE

Mar 2, 2023 · 1 like · 4,799 followers View post →

Sophia Ambruso

@sophia_kidney · X

RT @KIReports: 6/In an NEJM 2021 study, pts with AAV who were receiving standard induction therapy, the addition of avacopan was noninferio…

Jan 16, 2023 · 1 share · 1,973 followers View post →

KIReports

@KIReports · X

6/In an NEJM 2021 study, pts with AAV who were receiving standard induction therapy, the addition of avacopan was noninferior and not superior to the prednisone taper at week 26, but was superior to prednisone taper for sustained remission at week 52. https://t.co/P0ClhgEeQq

Jan 16, 2023 · 4 likes · 1 share · 13,558 followers View post →

ZoiAn

@ZoiAn2 · X

RT @vasculitides: Avacopan for the treatment of ANCA-associated vasculitis: an update - Expert Rev Clin Immunol https://t.co/9bRuhmbPEH

Jan 5, 2023 · 8 shares · 405 followers View post →

Roberto Gutiérrez

@DrRobertoGuti · X

RT @vasculitides: Avacopan for the treatment of ANCA-associated vasculitis: an update - Expert Rev Clin Immunol https://t.co/9bRuhmbPEH

Jan 3, 2023 · 8 shares · 782 followers View post →

Angela Córdoba Hurtado

@AngelaCordobaH · X

RT @vasculitides: Avacopan for the treatment of ANCA-associated vasculitis: an update - Expert Rev Clin Immunol https://t.co/9bRuhmbPEH

Jan 2, 2023 · 8 shares · 529 followers View post →

Carolina

@Carolinadzcbs · X

RT @vasculitides: Avacopan for the treatment of ANCA-associated vasculitis: an update - Expert Rev Clin Immunol https://t.co/9bRuhmbPEH

Jan 2, 2023 · 8 shares · 156 followers View post →

Dr Omar Eloy Muñoz

@omaremm28 · X

RT @vasculitides: Avacopan for the treatment of ANCA-associated vasculitis: an update - Expert Rev Clin Immunol https://t.co/9bRuhmbPEH

Jan 2, 2023 · 8 shares · 321 followers View post →

manuel macia heras

@mmacia25 · X

RT @vasculitides: Avacopan for the treatment of ANCA-associated vasculitis: an update - Expert Rev Clin Immunol https://t.co/9bRuhmbPEH

Jan 2, 2023 · 8 shares · 808 followers View post →

Mihir Kumar Jha

@diwtarni · X

RT @vasculitides: Avacopan for the treatment of ANCA-associated vasculitis: an update - Expert Rev Clin Immunol https://t.co/9bRuhmbPEH

Jan 2, 2023 · 8 shares · 180 followers View post →

vasculitides

@vasculitides · X

Avacopan for the treatment of ANCA-associated vasculitis: an update - Expert Rev Clin Immunol https://t.co/9bRuhmbPEH

Jan 1, 2023 · 22 likes · 8 shares · 4,784 followers View post →

Dr Omar Eloy Muñoz

@omaremm28 · X

RT @vasculitides: **Avacopan for the Treatment of ANCA-Associated Vasculitis - Clinical Trial - N Engl J Med https://t.co/SmzqRmAh8V

Oct 14, 2022 · 6 shares · 321 followers View post →

Annette Bruchfeld

@AnnetteBruchfe1 · X

@marie_holmqvist Jo, det var kombon CYC eller RTX tillsammans med antingen Avacopan eller Prednisolon som induktion vid AAV. Än så länge kan man bara ansöka om compassionate use för Avacopan i Sverige men är godkänt av EMA. https://t.co/eJezssdTUD

Sep 23, 2022 · 1 like · 2,293 followers View post →

NU Internal Medicine

@NU_IntMed · X

#NoonConference: Journal Club: NEJM article "Avacopan for the Treatment of ANCA-Associated Vasculitis" with Dr. Lee and Dr. Carrie Richardson https://t.co/pKhXOGXQxf

Sep 9, 2022 · 2 likes · 5,505 followers View post →

Isabelle Bourdeau

@IsaBourdeau · X

RT @com_SFNDT:

Aug 29, 2022 · 2 shares · 114 followers View post →

Nahid Tabibzadeh

@NahidTabibzadeh · X

RT @com_SFNDT:

Aug 29, 2022 · 2 shares · 902 followers View post →

SFNDT

@com_SFNDT · X

Aug 29, 2022 · 11 likes · 2 shares · 2,636 followers View post →

Dr Gurdeep S Dulay

@gurdeep_dulay · X

@doctorsaluja @vascuk Likely to be granted full NICE approval in UK *alongside* these as the phase 3 RCT was done in patients also on Cyclophosphamide/Rituximab https://t.co/BJunE696hK

Aug 18, 2022 · 2 likes · 3,694 followers View post →

nil

@nil_ahmedgil · X

Avacopan for the Treatment of ANCA-Associated Vasculitis | NEJM https://t.co/mgYOTcL3Hu

May 29, 2022 · 1 like · 96 followers View post →

ERA - European Renal Association

@ERAkidney · X

From ADVOCATE trial showing GFR recovery with avacopan. https://t.co/h44apCOzWr #ERA22 #GLOMera22 https://t.co/1HaRgxP2mk

May 21, 2022 · 5 likes · 20,728 followers View post →

Andrew

@andrewkwil · X

@JakeGeorge1839 @bigpharmaguy @Sanctuary_Bio https://t.co/lCtHw4oDjx https://t.co/kjENyzj5gs

May 9, 2022 · 136 followers View post →

Guanbo

@Haoguanbo · X

Tavneos (avacopan) for the Treatment of ANCA-Associated Vasculitis https://t.co/jeyAjvJ11u 来自 @Clinical Trials Arena

Apr 23, 2022 · 1 like · 16 followers View post →

soda_troubles,https://med-mastodon.com/@haysam

@set_fortess · X

RT @Vasculitis2022: A reminder of the ADVOCATE trial Methods were slightly complex Overall results previously published Read more here…

Apr 6, 2022 · 2 shares · 2,546 followers View post →

ZoiAn

@ZoiAn2 · X

RT @Vasculitis2022: A reminder of the ADVOCATE trial Methods were slightly complex Overall results previously published Read more here…

Apr 6, 2022 · 2 shares · 405 followers View post →

Vasculitis 2022

@Vasculitis2022 · X

A reminder of the ADVOCATE trial Methods were slightly complex Overall results previously published Read more here https://t.co/woLSQ3E6sf #Vasculitis22 https://t.co/UyDvCeG7rn

Apr 6, 2022 · 3 likes · 2 shares · 1,140 followers View post →

ACR_Journals

@ACR_Journals · X

Early view in ACR Open Access: Journal Club Review of “Avacopan for the Treatment of ANCA-Associated Vasculitis” https://t.co/9a1eyR7gOk

Mar 19, 2022 · 2 likes · 13,985 followers View post →

Mohamed Hamedh MSc, MD

@mohamedhamedh2 · X

Avacopan for the Treatment of ANCA-Associated Vasculitis | NEJM https://t.co/7X0WnX35yE

Mar 7, 2022 · 615 followers View post →

vasculitides

@vasculitides · X

Journal Club Review of "Avacopan for the Treatment of ANCA-Associated Vasculitis" - ACR Open Rheumatol https://t.co/VK5P3XA7yQ

Feb 22, 2022 · 4,784 followers View post →

Gabe

@IdVilchez · X

@LionakisLab @tmhohl71 https://t.co/wj5FqKCC6Y Understanding that is a new medication, I wanted to know more about how important is the complement terminal complex for the control of IFI. @GermHunterMD @FungalDoc @DrLuisO @ClancyNeil @DrNeilStone @Gnfidz @kierenamarr @cleverwebber

Jan 31, 2022 · 3 likes · 8,837 followers View post →

Stephan MorganMD,PhD-Duke

@StephanMorgan13 · X

RT @Pharmashot: ChemoCentryx’s Tavneos (avacopan) Receives EU Approval of TAVNEOS® (avacopan) for the Treatment of ANCA-Associated Vasculit…

Jan 20, 2022 · 1 share · 1,292 followers View post →

PharmaShots | Iluminate.Innovate.Inspire

@Pharmashot · X

ChemoCentryx’s Tavneos (avacopan) Receives EU Approval of TAVNEOS® (avacopan) for the Treatment of ANCA-Associated Vasculitis @Pharmashot https://t.co/lIcg9zulvW https://t.co/ISwtczShTE

Jan 20, 2022 · 1 share · 2,276 followers View post →

Reem Al-Jayyousi

@reemaljayyousi · X

RT @mxipell: Vifor Fresenius Medical Care Renal Pharma receives EU approval for Tavneos® (avacopan) for the treatment of ANCA-associated va…

Jan 19, 2022 · 6 shares · 166 followers View post →

Medicina Interna HUMT

@InternaHUMT · X

RT @mxipell: Vifor Fresenius Medical Care Renal Pharma receives EU approval for Tavneos® (avacopan) for the treatment of ANCA-associated va…

Jan 19, 2022 · 6 shares · 307 followers View post →

Jorge Álvarez Troncoso

@joraltron · X

RT @mxipell: Vifor Fresenius Medical Care Renal Pharma receives EU approval for Tavneos® (avacopan) for the treatment of ANCA-associated va…

Jan 19, 2022 · 6 shares · 2,306 followers View post →

Sergio Prieto

@sergioprietoglz · X

RT @mxipell: Vifor Fresenius Medical Care Renal Pharma receives EU approval for Tavneos® (avacopan) for the treatment of ANCA-associated va…

Jan 19, 2022 · 6 shares · 1,216 followers View post →

Choen

@Choen82920866 · X

ChemoCentryx Announces EU Approval of TAVNEOS® (avacopan) for the Treatment of ANCA-Associated Vasculitis https://t.co/1hImMwqhrb

Jan 19, 2022 · 2 likes · 5 followers View post →

SW6

@s6m6w6 · X

RT @BioStocks: $CCXI Announces EU Approval of TAVNEOS (avacopan) for the Treatment of ANCA-Associated Vasculitis

Jan 19, 2022 · 4 shares · 252 followers View post →

Maciej R

@realmaciej · X

RT @BioStocks: $CCXI Announces EU Approval of TAVNEOS (avacopan) for the Treatment of ANCA-Associated Vasculitis

Jan 19, 2022 · 4 shares · 681 followers View post →

Roberto Gutiérrez

@DrRobertoGuti · X

RT @mxipell: Vifor Fresenius Medical Care Renal Pharma receives EU approval for Tavneos® (avacopan) for the treatment of ANCA-associated va…

Jan 19, 2022 · 6 shares · 782 followers View post →

A Lara

@Alarar63 · X

RT @mxipell: Vifor Fresenius Medical Care Renal Pharma receives EU approval for Tavneos® (avacopan) for the treatment of ANCA-associated va…

Jan 19, 2022 · 6 shares · 37 followers View post →

stock setter

@MarcJacksonLA · X

$CCXI ChemoCentryx Announces EU Approval of TAVNEOS® (avacopan) for the Treatment of ANCA-Associated Vasculitis | BioSpace https://t.co/p2mEBv6ThZ #jobs

Jan 19, 2022 · 7,483 followers View post →

Lou Wallace

@Dw40031913 · X

ChemoCentryx Announces EU Approval of TAVNEOS® (avacopan) for the Treatment of ANCA-Associated Vasculitis - https://t.co/nInkSD4DPf Launch Expected in H1 2022 -- SAN CARLOS, Calif., Jan. 19, 2022 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that T... https://t.co/oTevce0DL7

Jan 19, 2022 · 360 followers View post →

Ryan

@rcdusk33 · X

https://t.co/clt7TqETVl https://t.co/clt7TqETVl @mikalche

Jan 19, 2022 · 37 followers View post →

BioTechDad

@SnackBioTech · X

RT @BioStocks: $CCXI Announces EU Approval of TAVNEOS (avacopan) for the Treatment of ANCA-Associated Vasculitis

Jan 19, 2022 · 4 shares · 1,948 followers View post →

Biostockinfo

@biostockinfo · X

RT @BioStocks: $CCXI Announces EU Approval of TAVNEOS (avacopan) for the Treatment of ANCA-Associated Vasculitis

Jan 19, 2022 · 4 shares · 99 followers View post →

Stockwits Acade〽️y

@mikalche · X

$CCXI ChemoCentryx Announces EU Approval of TAVNEOS® (avacopan) for the Treatment of ANCA-Associated Vasculitis

Jan 19, 2022 · 81,147 followers View post →

Phase Five

@phasefivebot · X

$CCXI ChemoCentryx Announces EU Approval of TAVNEOS® (avacopan) for the Treatment of ANCA-Associated Vasculitis https://t.co/TnqOorcRzY

Jan 19, 2022 · 75 followers View post →

Bio Stocks™

@BioStocks · X

$CCXI Announces EU Approval of TAVNEOS (avacopan) for the Treatment of ANCA-Associated Vasculitis

Jan 19, 2022 · 9 likes · 4 shares · 69,584 followers View post →

Flash Alert

@FlashAlert_me · X

$CCXI [15s. delayed]: Issued Press Release on January 19, 08:30:00: ChemoCentryx Announces EU Approval of TAVNEOS® (avacopan) for the Treatment of ANCA-Associated Vasculitis https://t.co/ZrHNfkfqsL

Jan 19, 2022 · 4,401 followers View post →

Quantisnow

@quantisnow · X

$CCXI

Jan 19, 2022 · 997 followers View post →

Marc Xipell

@mxipell · X

Vifor Fresenius Medical Care Renal Pharma receives EU approval for Tavneos® (avacopan) for the treatment of ANCA-associated vasculitis @MAS_Clinic @Miki_blasco @Allysonegan1 https://t.co/7ehNcLWGtt

Jan 19, 2022 · 11 likes · 6 shares · 498 followers View post →

Arkana Laboratories

@arkanalabs · X

Steroids have been the mainstay of treatment of patients with AAV, so it is amazing to think about a steroid-free regimen! #DiseaseWeek /14 https://t.co/lTVBbexSG7

Jan 13, 2022 · 10,906 followers View post →

YNP of ERA

@ynptweets · X

https://t.co/MGouoN79cw https://t.co/OJwe0rfrVt https://t.co/hMOKhi7OUg

Dec 21, 2021 · 4 likes · 3,796 followers View post →

バアニイ

@ilikevc · X

https://t.co/64zNKsYj7M GPAやMPAに対するアバコパン。ステロイドの副作用指標にGTI-CWS,AISが使われてるけどナニソレ気になる…

Dec 8, 2021 · 184 followers View post →

Mehrnaz Maleki Fischbach,MD, FACR

@maleki_md_farc · X

RT @Mehrnaz7777: Jayne DRW, Merkel PA, Schall TJ, Bekker P; ADVOCATE Study Group. Avacopan for the Treatment of ANCA-Associated Vasculitis.…

Nov 10, 2021 · 1 share · 164 followers View post →

Mehrnaz Maleki Fischbach,MD, FACR

@maleki_md_farc · X

Jayne DRW, Merkel PA, Schall TJ, Bekker P; ADVOCATE Study Group. Avacopan for the Treatment of ANCA-Associated Vasculitis. N Engl J Med. 2021 Feb 18;384(7):599-609. doi: 10.1056/NEJMoa2023386. PMID: 33596356. #ILDTwitterJC

Nov 10, 2021 · 1 like · 1 share · 164 followers View post →

Mehrnaz Maleki Fischbach,MD, FACR

@maleki_md_farc · X

Thank you for the introduction. I’m very excited to discuss: ADVOCATE trial - Avacopan for the Treatment of ANCA-Associated Vasculitis. #ILDTwitterJC

Nov 10, 2021 · 1 like · 164 followers View post →

National Jewish Health Medical Education

@NJHealthMedEd · X

In tonight’s #ILDTwitterJC chat, we’ll discuss Avacopan for the Treatment of ANCA-Associated Vasculitis. N Engl J Med 2021;384:599-609. DOI: 10.1056/NEJMoa2023386.

Nov 10, 2021 · 923 followers View post →

National Jewish Health Medical Education

@NJHealthMedEd · X

Tonight on Twitter! Use #ILDTwitterJC to join the conversation w/ Dr. Mehrnaz Maleki Fischbach to discuss Avacopan for the Treatment of ANCA-Associated #Vasculitis. The chat begins at 6pm PT, 7pm MT, 8pm CT, 9pm ET. #pulmtwitter #meded #ILDTwitterJC #lungdisease #rheumatology https://t.co/MCYaVg5TKe

Nov 10, 2021 · 1 like · 923 followers View post →

National Jewish Health Medical Education

@NJHealthMedEd · X

TODAY join Dr. Mehrnaz Maleki Fischbach on Zoom at 11:30am PT, 12:30pm MT, 1:30pm CT, 2:30pm ET to discuss Avacopan for the Treatment of ANCA-Associated #Vasculitis. Register here: https://t.co/W7eusLvWEY #pulmtwitter #meded #ILDTwitterJC #lungdisease #rheumatology @Mehrnaz7777 https://t.co/Amo691laiu

Nov 9, 2021 · 923 followers View post →

Gerald Ng

@GeraldNKL · X

RT @NatRevRheumatol: Clinical research Year in Review session at #ACR21 Links to all the papers discussed: 1. https://t.co/3XUsRcWwf1 and…

Nov 7, 2021 · 10 shares · 27 followers View post →

HADEF DJOHRA

@HDjohra · X

RT @NatRevRheumatol: Clinical research Year in Review session at #ACR21 Links to all the papers discussed: 1. https://t.co/3XUsRcWwf1 and…

Nov 6, 2021 · 10 shares · 19 followers View post →

Jose Luis Morell

@JlMorell · X

RT @NatRevRheumatol: Clinical research Year in Review session at #ACR21 Links to all the papers discussed: 1. https://t.co/3XUsRcWwf1 and…

Nov 6, 2021 · 10 shares · 2,762 followers View post →

MedEdBot

@MedEdBot · X

RT @NJHealthMedEd: Learn & earn CME! Join Dr. Mehrnaz Maleki Fischbach 11/9 & 11/10 to discuss "Avacopan for the Treatment of ANCA-Associat…

Nov 5, 2021 · 1 share · 2,911 followers View post →

National Jewish Health Medical Education

@NJHealthMedEd · X

Learn & earn CME! Join Dr. Mehrnaz Maleki Fischbach 11/9 & 11/10 to discuss "Avacopan for the Treatment of ANCA-Associated Vasculitis." Learn more here: https://t.co/dUrnSqlYzc #ILDTwitterJC #pulmtwitter #meded #vasculitis @Mehrnaz7777@accpCHEST @atscommunity @RheumILD @ACRRheum https://t.co/3fBdeqYKs6

Nov 5, 2021 · 1 like · 1 share · 923 followers View post →

Genessis Maldonado, MD, MCR

@gmaldonadovelez · X

RT @NatRevRheumatol: Clinical research Year in Review session at #ACR21 Links to all the papers discussed: 1. https://t.co/3XUsRcWwf1 and…

Nov 5, 2021 · 10 shares · 944 followers View post →

Herman Tam

@DrPedsRheum · X

Nov 5, 2021 · 1 like · 817 followers View post →

Tuhina Neogi, MD, PhD

@Tuhina_Neogi · X

RT @NatRevRheumatol: Clinical research Year in Review session at #ACR21 Links to all the papers discussed: 1. https://t.co/3XUsRcWwf1 and…

Nov 5, 2021 · 10 shares · 3,105 followers View post →

Melissa Mannion, MD, MSPH

@MannionMd · X

RT @NatRevRheumatol: Clinical research Year in Review session at #ACR21 Links to all the papers discussed: 1. https://t.co/3XUsRcWwf1 and…

Nov 5, 2021 · 10 shares · 338 followers View post →

Laura Lewandowski

@LauraLewMad11 · X

RT @NatRevRheumatol: Clinical research Year in Review session at #ACR21 Links to all the papers discussed: 1. https://t.co/3XUsRcWwf1 and…

Nov 5, 2021 · 10 shares · 2,411 followers View post →

Rheum Cat

@rheum_cat · X

RT @NatRevRheumatol: Clinical research Year in Review session at #ACR21 Links to all the papers discussed: 1. https://t.co/3XUsRcWwf1 and…

Nov 5, 2021 · 10 shares · 8,911 followers View post →

suzid

@drsuzdonnelly · X

RT @NatRevRheumatol: Clinical research Year in Review session at #ACR21 Links to all the papers discussed: 1. https://t.co/3XUsRcWwf1 and…

Nov 5, 2021 · 10 shares · 1,264 followers View post →

Latika

@LatikaGupta_ · X

RT @Yuz6Yusof: In case you're too busy this year #COVID19, #ACR21 Year in Clinical Review highlighted two landmark trials Avacopan in ANCA…

Nov 5, 2021 · 1 share · 6,505 followers View post →

Abraham E. Gracia R.

@Abraham_RMI · X

RT @NatRevRheumatol: Clinical research Year in Review session at #ACR21 Links to all the papers discussed: 1. https://t.co/3XUsRcWwf1 and…

Nov 5, 2021 · 10 shares · 4,680 followers View post →

Md Yuzaiful Md Yusof

@Yuz6Yusof · X

In case you're too busy this year #COVID19, #ACR21 Year in Clinical Review highlighted two landmark trials Avacopan in ANCA #vasculitis https://t.co/Q4VJtcSQmb and Voclosporin in #lupus nephritis https://t.co/d9a9Aa86OU; both FDA approved @RheumNow https://t.co/C9IqXAP5qj

Nov 5, 2021 · 4 likes · 1 share · 1,705 followers View post →

NatRevRheumatol

@NatRevRheumatol · X

Clinical research Year in Review session at #ACR21 Links to all the papers discussed: 1. https://t.co/3XUsRcWwf1 and https://t.co/RD4kU6Z04H 2. https://t.co/5slYDXq3AU 3. https://t.co/3sCRFZ1eVz and https://t.co/kVzE4U8RNL and https://t.co/z6Cqvz1WrG 1/2

Nov 5, 2021 · 24 likes · 10 shares · 18,809 followers View post →

Laura Lewandowski

@LauraLewMad11 · X

RT @rheum_cat: ADVOCATE: Avacopan for ANCA vasculitis Promising new therapy for ANCA vasculitis: Met non-inferiority vs PO prednisone for…

Nov 5, 2021 · 1 share · 2,411 followers View post →

sheila

@RHEUMarampa · X

#ACR21 #YearinReview Avacopan: The game changer for ANCA #vasculitis?

Nov 5, 2021 · 20 likes · 8 shares · 1,145 followers View post →

Rheum Cat

@rheum_cat · X

ADVOCATE: Avacopan for ANCA vasculitis Promising new therapy for ANCA vasculitis: Met non-inferiority vs PO prednisone for remission at 26wks, sustained remission at 52 wks, and prevention of relapse https://t.co/eO6EitTzbr #ACR21 https://t.co/n1uTvC5fYN

Nov 5, 2021 · 1 like · 1 share · 8,911 followers View post →

Dr. Fermin Gonzalez

@fermin98380786 · X

RT @rheumthusiastic: With the FDA approval of Avacopan for ANCA-Associated Vasculitis. Let's start a discussion about the ADVOCATE trial wi…

Oct 15, 2021 · 2 shares · 590 followers View post →

Dr Sultana Abdulaziz

@drsabdulaziz · X

Avacopan for the Treatment of ANCA-Associated Vasculitis | NEJM https://t.co/iIIEK3scyy

Oct 12, 2021 · 376 followers View post →

Jorge Luis Rodríguez .

@JL____Rodriguez · X

RT @IlindelatorreMD: La FDA aprueba avacopan (Tavneos) para el tratamiento de la granulomatosis con poliangeítis y de la poliangeítis micro…

Oct 9, 2021 · 2 shares · 1,350 followers View post →

Dr. Ilin Gilberto de la Torre M.

@IlindelatorreMD · X

La FDA aprueba avacopan (Tavneos) para el tratamiento de la granulomatosis con poliangeítis y de la poliangeítis microscópica. Avacopan es un inhibidor del receptor oral del complemento 5a. https://t.co/5u7FAaua3q https://t.co/AlEXoNpdCT

Oct 9, 2021 · 13 likes · 2 shares · 45,842 followers View post →

Fadel Alrowaie

@fadelrowaie · X

ADVOCATE STUDY : Avacopan for the Treatment of ANCA-Associated Vasculitis | NEJM published I Feb 2021 https://t.co/NKbqSUdc8g

Oct 8, 2021 · 5 likes · 25,017 followers View post →

Mervat Eissa

@dr_mervateissa · X

Avacopan for the Treatment of ANCA-Associated Vasculitis | NEJM https://t.co/kyPPrLBXzA

Oct 8, 2021 · 390 followers View post →

Dimitris Mastellos

@dmastellos · X

The results of the Ph III ADVOCATE trial that instigated the process for avacopan's approval were published in NEJM back in February: https://t.co/uhkoOai4J9

Oct 8, 2021 · 1 like · 589 followers View post →

AETOSWire

@AETOSWire · X

VFMCRP announces approval for TAVNEOS® (avacopan) for the treatment of ANCA-associated vasculitis in #Japan https://t.co/GWVpuGzwpa #treatment #heakth #HealthInsurance #AETOSWire https://t.co/sgVVGmiQVz

Sep 29, 2021 · 1,139 followers View post →

Algeria Times

@Alg_Times · X

#VFMCRP announces approval for TAVNEOS® (avacopan) for the #treatment of ANCA-associated #vasculitis in Japan https://t.co/yHnpAYrTAB

Sep 29, 2021 · 55 followers View post →

Al Sham Info

@Alsham_Info · X

#VFMCRP announces approval for TAVNEOS® (avacopan) for the #treatment of ANCA-associated #vasculitis in Japan https://t.co/4bZ2PTPbSP

Sep 29, 2021 · 31 followers View post →

Tunis Daily News

@Tunis_Daily · X

#VFMCRP announces approval for TAVNEOS® (avacopan) for the treatment of ANCA-associated vasculitis in Japan https://t.co/Vzm94iKDTn

Sep 28, 2021 · 35 followers View post →

Saudi Daily Record

@SAUDI_Daily · X

#VFMCRP announces approval for TAVNEOS® (avacopan) for the treatment of ANCA-associated vasculitis in Japan https://t.co/dH0P1zdfcq

Sep 28, 2021 · 1,816 followers View post →

Libya Business Info

@Libya_Biz_Info · X

VFMCRP announces approval for TAVNEOS® (avacopan) for the treatment of ANCA-associated vasculitis in Japan https://t.co/n0hVPbucKg

Sep 28, 2021 · 26 followers View post →

Doha Insight

@insight_doha · X

VFMCRP announces approval for TAVNEOS® (avacopan) for the treatment of ANCA-associated vasculitis in Japan https://t.co/2CMhRVdKhU

Sep 28, 2021 · 1,306 followers View post →

Algeria Business Info

@AlgeriaTweets · X

VFMCRP announces approval for TAVNEOS® (avacopan) for the treatment of ANCA-associated vasculitis in Japan https://t.co/ynMgT5dhaf

Sep 28, 2021 · 2,280 followers View post →

lglmrc

@lglmrc · X

$CCXI ChemoCentryx Announces Approval in Japan of TAVNEOS™ (Avacopan) for the Treatment of ANCA-Associated Vasculitis

Sep 28, 2021 · 1,729 followers View post →

뉴스와이어

@koreanewswire · X

VFMCRP announces approval for TAVNEOS® (avacopan) for the treatment of ANCA-associated vasculitis in Japan https://t.co/O31uiWx0EP

Sep 28, 2021 · 5,320 followers View post →

뉴스와이어 - 건강

@newswire_sc · X

VFMCRP announces approval for TAVNEOS® (avacopan) for the treatment of ANCA-associated vasculitis in Japan https://t.co/7MbtKfFXGa

Sep 28, 2021 · 152 followers View post →

Dividend Super Reactor

@elmicla · X

$CCXI ($19) have Avacopan for the Treatment of ANCA-Associated Vasculitis. Four months ago the FDA did not approved and the stock fell from $65. On 07/Oct/21 the FDA will review the new data provided and make a final decision. Today, Japan approved! which is a Big Sign of Hope!!! https://t.co/ZRv7YIefJr

Sep 27, 2021 · 5 likes · 180 followers View post →

Jase Jones

@astockwatch1 · X

ChemoCentryx Announces Approval in Japan of TAVNEOS™ (Avacopan) for the Treatment of ANCA-Associated Vasculitis https://t.co/3NCNj1hFo1 $ccxi #stockstobuy #stocks2buy #stockstobuytoday #stocks.

Sep 27, 2021 · 1 like · 1,913 followers View post →

Dividend Super Reactor

@elmicla · X

$CCXI ChemoCentryx Announces Approval in Japan of TAVNEOS™ (Avacopan) for the Treatment of ANCA-Associated Vasculitis https://t.co/WsIfDRjwRV

Sep 27, 2021 · 1 like · 180 followers View post →

Indian Conventions - Webzine

@IndConWebzine · X

[RT] #VFMCRP announces approval for TAVNEOS® (avacopan) for the treatment of ANCA-associated vasculitis in Japan https://t.co/pNC8AT51oS

Sep 27, 2021 · 184 followers View post →

Khadim Shah

@Kshaahji · X

RT @FlashAlert_me: $CCXI [15s. delayed]: Issued Press Release on September 27, 08:30:00: ChemoCentryx Announces Approval in Japan of TAVNEO…

Sep 27, 2021 · 1 share · 65 followers View post →

MedFirst - MedComms

@MedFirstLtd · X

ChemoCentryx Announces Approval in Japan of TAVNEOS™ (Avacopan) for the Treatment of ANCA-Associated Vasculitis - Yahoo Finance https://t.co/WoxkNUgBX4 • https://t.co/le73xfO7Nb

Sep 27, 2021 · 178 followers View post →

Jase Jones

@astockwatch1 · X

ChemoCentryx Announces Approval in Japan of TAVNEOS™ (Avacopan) for the Treatment of ANCA-Associated Vasculitis #fdaapproval #fda #stocks #news $ccxi https://t.co/2SfuI3pyqI

Sep 27, 2021 · 1 like · 1,913 followers View post →

Phase Five

@phasefivebot · X

$CCXI ChemoCentryx Announces Approval in Japan of TAVNEOS™ (Avacopan) for the Treatment of ANCA-Associated Vasculitis https://t.co/P2Gh8hAw3B

Sep 27, 2021 · 1 like · 75 followers View post →

Flash Alert

@FlashAlert_me · X

$CCXI [15s. delayed]: Issued Press Release on September 27, 08:30:00: ChemoCentryx Announces Approval in Japan of TAVNEOS™ (Avacopan) for the Treatment of ANCA-Associated Vasculitis https://t.co/7e6w8EHHLh

Sep 27, 2021 · 1 like · 1 share · 4,401 followers View post →

Quantisnow

@quantisnow · X

$CCXI

Sep 27, 2021 · 997 followers View post →

Pharmacutical Daily

@PharmacDaily · X

VFMCRP announces approval for TAVNEOS® (avacopan) for the treatment of ANCA-associated vasculitis in Japan https://t.co/0tCLB3dOht

Sep 27, 2021 · 1,524 followers View post →

MasMaz

@MasMazCom · X

VFMCRP announces approval for TAVNEOS® (avacopan) for the treatment of ANCA-associated vasculitis in Japan - https://t.co/Pwk1sutMZq https://t.co/A5O1olpbfu

Sep 27, 2021 · 169 followers View post →

Dataemia

@Dataemia · X

VFMCRP announces approval for TAVNEOS® (avacopan) for the treatment of ANCA-associated vasculitis in Japan - https://t.co/IJq1rY1lI4 https://t.co/UZsTpCrnaR

Sep 27, 2021 · 966 followers View post →

Avacopan for the Treatment of ANCA-Associated Vasculitis.

Mentions per month

Where it's discussed

What people are saying

Abstract in brief

Top posts

All mentions

Nephrology Insights 2022: New Treatments for Chronic Kidney Disease

Best Practices for Glucocorticoid Therapy in Lupus Nephritis